New York University Clinical Cancer Center — New York, New York

New York University Clinical Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

New York University Clinical Cancer Center has participated in 20 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Recurrent Melanoma, Stage IV Melanoma.

Sponsors: Stemline Therapeutics, Inc., National Cancer Institute (NCI), Replimune Inc..

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Clinical Cancer Center?

New York University Clinical Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Clinical Cancer Center conducted?

New York University Clinical Cancer Center has 20 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Recurrent Melanoma, Stage IV Melanoma.

Is New York University Clinical Cancer Center accredited by Crixeo Health?

Yes — New York University Clinical Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Clinical Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.